Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry YS Ooi, KM Stiles, CY Liu, GM Taylor, M Kielian PLoS pathogens 9 (12), e1003835, 2013 | 111 | 2013 |
Haploid genetic screen reveals a profound and direct dependence on cholesterol for hantavirus membrane fusion LM Kleinfelter, RK Jangra, LT Jae, AS Herbert, E Mittler, KM Stiles, ... MBio 6 (4), 10.1128/mbio. 00801-15, 2015 | 108 | 2015 |
Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition KM Stiles, JC Whitbeck, H Lou, GH Cohen, RJ Eisenberg, ... Journal of virology 84 (22), 11646-11660, 2010 | 66 | 2010 |
The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D KM Stiles, RSB Milne, GH Cohen, RJ Eisenberg, C Krummenacher Virology 373 (1), 98-111, 2008 | 63 | 2008 |
Genetic modification of the lung directed toward treatment of human disease D Sondhi, KM Stiles, BP De, RG Crystal Human gene therapy 28 (1), 3-84, 2017 | 62 | 2017 |
Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entry KM Stiles, C Krummenacher Virology 399 (1), 109-119, 2010 | 42 | 2010 |
The ATPase motif in RAD51D is required for resistance to DNA interstrand crosslinking agents and interaction with RAD51C AM Gruver, KA Miller, C Rajesh, PG Smiraldo, S Kaliyaperumal, R Balder, ... Mutagenesis 20 (6), 433-440, 2005 | 41 | 2005 |
Gene therapy correction of aldehyde dehydrogenase 2 deficiency Y Matsumura, KM Stiles, J Reid, EZ Frenk, S Cronin, OE Pagovich, ... Molecular Therapy-Methods & Clinical Development 15, 72-82, 2019 | 35 | 2019 |
Role of TSPAN9 in alphavirus entry and early endosomes KM Stiles, M Kielian Journal of virology 90 (9), 4289-4297, 2016 | 30 | 2016 |
Stress-induced mouse model of the cardiac manifestations of Friedreich's ataxia corrected by AAV-mediated gene therapy CO Salami, K Jackson, C Jose, L Alyass, GI Cisse, BP De, KM Stiles, ... Human Gene Therapy 31 (15-16), 819-827, 2020 | 21 | 2020 |
Intrapleural gene therapy for alpha-1 antitrypsin deficiency-related lung disease KM Stiles, D Sondhi, SM Kaminsky, BP De, JB Rosenberg, RG Crystal Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 5 (4 …, 2018 | 20 | 2018 |
Anti-phospho-tau gene therapy for chronic traumatic encephalopathy CB Sacramento, D Sondhi, JB Rosenberg, A Chen, S Giordano, E Pey, ... Human gene therapy 31 (1-2), 57-69, 2020 | 19 | 2020 |
Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin ML Sosulski, KM Stiles, EZ Frenk, FM Hart, Y Matsumura, BP De, ... JCI insight 5 (15), 2020 | 16 | 2020 |
Alphavirus entry: NRAMP leads the way KM Stiles, M Kielian Cell host & microbe 10 (2), 92-93, 2011 | 16 | 2011 |
Gene therapy for a murine model of eosinophilic esophagitis AE Camilleri, S Nag, AR Russo, KM Stiles, RG Crystal, OE Pagovich Allergy 76 (9), 2740-2752, 2021 | 13 | 2021 |
Systemic adeno-associated virus-mediated gene therapy prevents the multiorgan disorders associated with aldehyde dehydrogenase 2 deficiency and chronic ethanol ingestion Y Matsumura, N Li, H Alwaseem, OE Pagovich, RG Crystal, ... Human Gene Therapy 31 (3-4), 163-182, 2020 | 8 | 2020 |
Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency RA Montel, C Munoz-Zuluaga, KM Stiles, RG Crystal Cancer gene therapy 29 (7), 889-896, 2022 | 3 | 2022 |
Genetic modification of the AAV5 capsid with lysine residues results in a lung-tropic liver-detargeted gene transfer vector KM Stiles, EZ Frenk, SM Kaminsky, RG Crystal Human Gene Therapy 33 (3-4), 148-154, 2022 | 3 | 2022 |
AAV-mediated anti-eosinophil gene therapy for eosinophilic esophagitis OE Pagovich, AE Camilleri, S Nag, KM Stiles, RG Crystal MOLECULAR THERAPY 28 (4), 90-91, 2020 | 3 | 2020 |
Gene therapy for chronic eosinophilic leukemia OE Pagovich, S Nag, AE Camilleri, KM Stiles, RG Crystal MOLECULAR THERAPY 27 (4), 166-166, 2019 | 3 | 2019 |